Glucose-functionalized Iron Oxide Nanoparticles Which Co-conjugated with Hyaluronic Acid and Naringenin Induces ROS-mediated Apoptosis and Cell Cycle Arrest in Colon Cancer Cells

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 26

فایل این مقاله در 15 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_SGR-12-2_007

تاریخ نمایه سازی: 21 آبان 1405

چکیده مقاله:

Targeted drug delivery has received attention in cancer chemotherapy. In the present study, glucose (Glu)-functionalized iron oxide nanoparticles (Fe۳O۴ NPs) were co-conjugated with hyaluronic acid (HA) and naringenin (NAR), and their anticancer potential against colon cancer cells was characterized. Properties of Fe۳O۴@Glu-HA-NAR NPs were investigated by SEM, DLS, zeta potential, FT-IR, and XRD analyses. Cytotoxicity of the NPs in HT-۱۱۶ and HDF cell lines was investigated by an MTT assay. The effects of the Fe۳O۴@Glu-HA-NAR NPs on cell cycle and apoptosis/necrosis in HT-۱۱۶ cell line was studied by flow cytometry. AO/PI staining and real-time PCR were employed to evaluate nuclear morphology and expression of caspase-۸ gene in the cancer cells, and reactive oxygen species (ROS) levels were also determined. The Fe۳O۴@Glu-HA-NAR NPs exhibited spherical to cubic morphology, an average particle size of ۷۷.۶ nm, surface charge of -۵۷.۹ mV, hydrodynamic size of ۷۸۳ nm, and structural characteristics similar to their constituent components. Fe۳O۴@Glu-HA-NAR nanoparticles demonstrated concentration-dependent cytotoxicity toward the studied cells with greater toxicity against HT-۱۱۶ cells [۵۰% inhibitory concentration (IC۵۰) = ۴۲.۶۳ μg/mL]. In comparison, free NAR exhibited a higher IC₅₀ value (۶۴.۶۲ μg/mL), indicating that nanoparticle-mediated delivery enhanced the antiproliferative efficacy of NAR against colon cancer cells. Treatment of the HT-۱۱۶ cells with Fe۳O۴@Glu-HA-NAR NPs blocked cell cycle progression at the S and G۲/M phases, elevated cell necrosis and late apoptosis and caused nuclear alterations, including chromatin condensation. Exposure to Fe۳O۴@Glu-HA-NAR significantly upregulated the expression of the CASP-۸ gene (۳.۸-fold) and increased ROS levels by ۱۳.۰-fold. This study demonstrates the promising potential of Fe۳O۴@Glu-HA-NAR NPs in targeting colon cancer cells.

نویسندگان

Yaser Mohammadi

Department of Biochemistry, NT.C., Islamic Azad University, Tehran, Iran

Fariba Sharifnia

Department of Biochemistry, NT.C., Islamic Azad University, Tehran, Iran

Monireh Movahedi

Department of Biochemistry, NT.C., Islamic Azad University, Tehran, Iran

Ali Salehzadeh

Department of Biology, Ra.C., Islamic Azad University, Rasht, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Ahmadzadeh Chaleshtori, M. A., Salehzadeh, A., & Peymani, M. (۲۰۲۵). ...
  • Chang, T. M., Chi, M. C., Chiang, Y. C., Lin, ...
  • De Luna, F. C. F., Ferreira, W. A. S., Casseb, ...
  • De Souza, W. R., Quevedo, B. V., Garcia, P. S., ...
  • Demchenko, A. P. (۲۰۱۳). Beyond annexin V: Fluorescence response of ...
  • Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (۲۰۱۶). ...
  • Esfahani, M. A., Salehzadeh, A., & Ghobeh, M. (۲۰۲۴). Anti-proliferative ...
  • Fu, C. P., Cai, X. Y., Chen, S. L., Yu, ...
  • Gambhir, R. P., Rohiwal, S. S., & Tiwari, A. P. ...
  • Haleem, A., Javaid, M., Singh, R. P., Rab, S., & ...
  • Hosseinkhah, M., Ghasemian, R., Shokrollahi, F., Mojdehi, S. R., Noveiri, ...
  • Heydari, M., Colagar, A. H., Sabour, D., & Khorasani, H. ...
  • Heydari, M., Colagar, A. H., & Sabour, D. (۲۰۲۵). Anti-proliferative ...
  • Jia, Y., Chen, S., Wang, C., Sun, T., & Yang, ...
  • Kazemzadeh, D., Salehzadeh, A., Shariati, S., & Shandiz, S. A. ...
  • Kumari, R., Saini, A. K., Kumar, A., & Saini, R. ...
  • Lee, H. C., Huang, K. H., Chi, M. C., Lee, ...
  • Lozano-Herrera, S. J., Luna-Barcenas, G., Guevara-Gonzalez, R. G., Campos-Vega, R., ...
  • Lu, D., Chen, J., & Hai, T. (۲۰۰۷). The regulation ...
  • Michalczyk, M., Humeniuk, E., Adamczuk, G., & Korga-Plewko, A. (۲۰۲۲). ...
  • Najafipour, I., Emami, N., Sadeh, P., Amoli, A., Mosleh-Shirazi, S., ...
  • Noman, A.M., Sultan, M.T., Raza, H., Imran, M., Hussain, M., ...
  • Oki, E., Ando, K., Taniguchi, H., Yoshino, T., & Mori, ...
  • Pan, D. C., Krishnan, V., Salinas, A. K., Kim, J., ...
  • Pantelis, P., Theocharous, G., Lagopati, N., Veroutis, D., Thanos, D. ...
  • Parashar, P., Rathor, M., Dwivedi, M., & Saraf, S. A. ...
  • Pfaffl, M. W. (۲۰۰۱). A new mathematical model for relative ...
  • Phatak, N., Bhattacharya, S., Shah, D., Manthalkar, L., Sreelaya, P., ...
  • Ramezani, T., Nabiuni, M., Baharara, J., Parivar, K., & Namvar, ...
  • Rauf, A., Shariati, M. A., Imran, M., Bashir, K., Khan, ...
  • Saiprasad, G., Chitra, P., Manikandan, R., Koodalingam, A., & Sudhandiran, ...
  • Sharma, T., Gorivale, S., & Bhandari, P. (۲۰۲۴). Targeted drug ...
  • Song, H. M., Park, G. H., Eo, H. J., & ...
  • Stabrauskiene, J., Kopustinskiene, D. M., Lazauskas, R., & Bernatoniene, J. ...
  • Stanicki, D., Vangijzegem, T., Ternad, I., & Laurent, S. (۲۰۲۲). ...
  • Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, ...
  • Wang, B., Wang, Y., Zhang, J., Hu, C., Jiang, J., ...
  • Wang, D., Zhou, Y., Hua, L., Hu, M., Zhu, N., ...
  • Xie, Y., Zhou, J., Zhang, B., Zhang, L., Yang, D., ...
  • Yilmaz, M. D., Ozsamur, N. G., & Erbas-Cakmak, S. (۲۰۲۴). ...
  • Zamanian, M. Y., Golmohammadi, M., Abdullaev, B., Garcia, M. O., ...
  • Zhang, M., Lai, J., Wu, Q., Lai, J., Su, J., ...
  • Zhao, Y., Fan, D., Ru, B., Cheng, K.W., Hu, S., ...
  • Zhao, Y., Ye, X., Xiong, Z., Ihsan, A., Ares, I., ...
  • Zeya, B., Nafees, S., Imtiyaz, K., Uroog, L., Fakhri, K.U., ...
  • نمایش کامل مراجع